VCEL
Vericel Corporation
NasdaqGMUSDEQUITY
Healthcare
DELAYED
Buy
+20/100
Last price
40.05
▼ 1.02 (2.48%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Overlay another symbol
Both series are rebased to 0% at the left edge, so the lines show relative performance rather than price.
Tool
1D
—
H —
L —
Range —
Vol —
vs
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
41.33
Prev close
41.07
Day high
41.45
Day low
39.66
Volume
669.04K
Market cap
$2.05B
P/E (TTM)
85.21
52W range
28.95 – 49.32
Day trading desk
Gap from prior close
+0.63%
Prior close 41.07
VWAP
40.18
-0.32% from price
Relative volume
2.47×
Unusually busy
Session range
6.33%
39.50 – 42.00
Position in range
22%
Near session low
ATR (14D)
1.25
3.11% of price
Prior day high
41.17
PDH
Prior day low
39.93
PDL
Bid / ask spread
—
Quote not published
Session volume
1.24M
Avg 501.90K
VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.
Trailing performance
Returnvs SPY
1W
-1.38%
-3.3%
1M
-0.35%
-1.5%
3M
-14.82%
-19.3%
6M
+20.16%
+2.0%
YTD
+11.22%
-3.0%
1Y
+23.46%
+7.0%
3Y
+19.48%
-62.8%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on VCEL open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
-5.89K
Net selling
Buy transactions
16
104.58K shares
Sell transactions
14
110.46K shares
Net transactions
+30
Buys less sells
Sell : buy shares
1.1 : 1
Mixed
Insider-held shares
609.36K
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Aug 12, 26 | MCLAUGHLIN KEVIN F Director |
SELL | 7.00K | $311.71K | Direct |
| Aug 12, 26 | MCLAUGHLIN KEVIN F Director |
CONVERSION | 7.00K | $91.35K | Direct |
| Aug 3, 26 | HALPIN MICHAEL Chief Operating Officer |
SELL | 10.00K | $468.40K | Direct |
| Aug 3, 26 | HALPIN MICHAEL Chief Operating Officer |
CONVERSION | 10.00K | $166.60K | Direct |
| Jul 30, 26 | SIEGAL JONATHAN D. Officer |
SELL | 4.50K | $220.05K | Direct |
| Jul 30, 26 | SIEGAL JONATHAN D. Officer |
CONVERSION | 4.50K | $141.81K | Direct |
| Jun 26, 26 | HOPPER JONATHAN MARK Officer |
SELL | 10.00K | $450.00K | Direct |
| Jun 26, 26 | HOPPER JONATHAN MARK Officer |
CONVERSION | 10.00K | $298.20K | Direct |
| Jun 26, 26 | FLYNN SEAN C Officer |
SELL | 15.00K | $684.60K | Direct |
| Jun 26, 26 | FLYNN SEAN C Officer |
CONVERSION | 15.00K | $243.75K | Direct |
| Jun 26, 26 | MARA JOSEPH ANTHONY JR Chief Financial Officer |
SELL | 5.00K | $223.75K | Direct |
| Jun 26, 26 | SIEGAL JONATHAN D. Officer |
SELL | 2.73K | $122.67K | Direct |
| Jun 26, 26 | SIEGAL JONATHAN D. Officer |
CONVERSION | 2.50K | $74.55K | Direct |
| Jun 18, 26 | HALPIN MICHAEL Chief Operating Officer |
SELL | 10.00K | $402.40K | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
COLANGELO DOMINICK C |
Chief Executive Officer | 312.45K | Conversion of Exercise of derivative security |
HAGEN HEIDI M. |
Director | 35.05K | Conversion of Exercise of derivative security |
HALPIN MICHAEL |
Chief Operating Officer | 16.39K | Sale |
HOPPER JONATHAN MARK |
Officer | 75.75K | Sale |
MARA JOSEPH ANTHONY JR |
Chief Financial Officer | 16.01K | Sale |
MCLAUGHLIN KEVIN F |
Director | 18.30K | Sale |
RUBINO ALAN L |
Director | 64.19K | Conversion of Exercise of derivative security |
WOTTON PAUL K |
Director | 18.80K | Sale |
WRIGHT LISA |
Director | 15.85K | Conversion of Exercise of derivative security |
ZERBE ROBERT L |
Director | 32.99K | Conversion of Exercise of derivative security |
Fundamentals
Market cap$2.05B
Enterprise value$1.98B
Revenue (TTM)$306.30M
Gross profit$228.38M
EBITDA$31.15M
Net income$24.22M
EPS (TTM)$0.47
Free cash flow$55.54M
Total cash$162.46M
Total debt$93.13M
Book value / share$7.23
Shares outstanding51.21M
Float50.58M
Short % of float13.79%
Dividend yield0.00%
Beta (5Y)1.03
Valuation & profitability ratios
Trailing P/E85.21
Forward P/E47.34
PEG ratio—
Price / sales—
Price / book5.54
EV / revenue6.47
EV / EBITDA63.60
Gross margin74.56%
Operating margin0.56%
Profit margin7.91%
Return on equity7.16%
Return on assets2.43%
Debt / equity25.17
Current ratio5.04
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $276.26M | $237.22M | $197.52M | $164.37M | +16.5% |
| Operating revenue | $276.26M | $237.22M | $197.52M | $163.70M | +16.5% |
| Cost of revenue | $70.66M | $65.12M | $61.94M | $54.58M | +8.5% |
| Gross profit | $205.60M | $172.11M | $135.58M | $109.79M | +19.5% |
| Research & development | $27.56M | $24.80M | $21.04M | $19.94M | +11.2% |
| Selling, general & admin | $166.99M | $142.79M | $121.00M | $106.90M | +16.9% |
| Total operating expense | $194.56M | $167.59M | $142.04M | $126.85M | +16.1% |
| Operating income | $11.04M | $4.52M | -$6.46M | -$17.06M | +144.4% |
| Net interest income | $6.38M | $5.80M | $4.03M | $975.00K | +10.0% |
| Pre-tax income | $17.38M | $10.51M | -$2.37M | -$15.99M | +65.3% |
| Tax provision | $859.00K | $148.00K | $814.00K | $721.00K | +480.4% |
| Net income | $16.52M | $10.36M | -$3.18M | -$16.71M | +59.4% |
| Net income to common | $16.52M | $10.36M | -$3.18M | -$16.71M | +59.4% |
| Basic EPS | 0.33 | 0.21 | -0.07 | -0.35 | +57.1% |
| Diluted EPS | 0.32 | 0.20 | -0.07 | -0.35 | +60.0% |
| EBIT | $18.01M | $11.12M | -$1.77M | -$15.62M | +61.9% |
| EBITDA | $29.55M | $16.63M | $2.86M | -$11.64M | +77.7% |
| Basic shares | 50.34M | 48.85M | 47.59M | 47.13M | +3.1% |
| Diluted shares | 52.15M | 51.68M | 47.59M | 47.13M | +0.9% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $100.09M | $74.52M | $69.09M | $51.07M | +34.3% |
| Cash & short-term investments | $137.50M | $116.21M | $109.56M | $119.54M | +18.3% |
| Accounts receivable | $84.63M | $61.38M | $58.36M | $46.54M | +37.9% |
| Inventory | $17.56M | $17.37M | $13.09M | $15.99M | +1.1% |
| Total current assets | $247.44M | $212.78M | $205.63M | $186.87M | +16.3% |
| Property, plant & equipment | $173.17M | $173.26M | $115.10M | $57.37M | -0.1% |
| Goodwill & intangibles | $5.63M | $6.25M | $6.88M | $7.50M | -10.0% |
| Total assets | $487.97M | $432.72M | $353.66M | $273.00M | +12.8% |
| Total current liabilities | $49.15M | $50.29M | $45.75M | $37.46M | -2.3% |
| Total debt | $96.37M | $98.97M | $88.04M | $47.57M | -2.6% |
| Total liabilities | $133.33M | $140.75M | $127.70M | $80.73M | -5.3% |
| Retained earnings | -$376.30M | -$392.81M | -$403.18M | -$400.00M | +4.2% |
| Shareholder equity | $354.64M | $291.97M | $225.95M | $192.27M | +21.5% |
| Working capital | $198.29M | $162.49M | $159.88M | $149.40M | +22.0% |
| Net tangible assets | $349.01M | $285.72M | $219.08M | $184.77M | +22.2% |
| Shares issued | 50.62M | 49.63M | 47.83M | 47.25M | +2.0% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Net income | $16.52M | $10.36M | -$3.18M | -$16.71M | +59.4% |
| Depreciation & amortisation | $11.54M | $5.50M | $4.63M | $3.98M | +109.7% |
| Stock-based compensation | $38.77M | $36.49M | $32.33M | $37.18M | +6.2% |
| Change in working capital | -$21.36M | -$450.00K | -$3.96M | -$11.21M | -4,646.0% |
| Operating cash flow | $51.91M | $58.16M | $35.31M | $17.69M | -10.8% |
| Capital expenditure | -$27.16M | -$63.97M | -$27.51M | -$7.60M | +57.5% |
| Investing cash flow | -$43.94M | -$79.03M | -$3.13M | -$36.21M | +44.4% |
| Financing cash flow | $7.07M | $19.05M | $3.62M | $1.04M | -62.9% |
| Free cash flow | $24.75M | -$5.81M | $7.80M | $10.09M | +525.9% |
| End cash position | $100.09M | $85.05M | $86.87M | $51.07M | +17.7% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | $77.46M | $68.42M | $92.92M | $67.50M | $63.24M | +13.2% |
| Operating revenue | $77.46M | $68.42M | $92.92M | $67.50M | $63.24M | +13.2% |
| Cost of revenue | $21.05M | $19.16M | $19.79M | $17.92M | $16.63M | +9.9% |
| Gross profit | $56.40M | $49.27M | $73.13M | $49.59M | $46.61M | +14.5% |
| Research & development | $7.49M | $8.10M | $7.25M | $6.32M | $6.73M | -7.5% |
| Selling, general & admin | $48.48M | $49.23M | $43.46M | $39.82M | $41.91M | -1.5% |
| Total operating expense | $55.97M | $57.33M | $50.71M | $46.13M | $48.64M | -2.4% |
| Operating income | $434.00K | -$8.06M | $22.41M | $3.45M | -$2.03M | +105.4% |
| Net interest income | $1.79M | $1.69M | $1.72M | $1.65M | $1.50M | +6.1% |
| Pre-tax income | $2.21M | -$6.30M | $24.10M | $5.07M | -$553.00K | +135.0% |
| Net income | $2.21M | -$6.30M | $23.24M | $5.07M | -$553.00K | +135.0% |
| Net income to common | $2.21M | -$6.30M | $23.24M | $5.07M | -$553.00K | +135.0% |
| Basic EPS | 0.04 | -0.12 | 0.46 | 0.10 | -0.01 | +133.3% |
| Diluted EPS | 0.04 | -0.12 | 0.45 | 0.10 | -0.01 | +133.3% |
| EBIT | $2.37M | -$6.14M | $24.26M | $5.23M | -$396.00K | +138.5% |
| EBITDA | $5.99M | -$2.88M | $27.35M | $8.18M | $2.43M | +308.2% |
| Basic shares | 51.08M | 50.77M | 50.59M | 50.49M | 50.37M | +0.6% |
| Diluted shares | 52.31M | 50.77M | 52.07M | 51.91M | 50.37M | +3.0% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $125.36M | $109.30M | $100.09M | $100.40M | $80.53M | +14.7% |
| Cash & short-term investments | $162.46M | $145.34M | $137.50M | $135.38M | $116.88M | +11.8% |
| Accounts receivable | $75.71M | $72.38M | $84.63M | $60.43M | $64.29M | +4.6% |
| Inventory | $18.38M | $18.35M | $17.56M | $18.16M | $16.83M | +0.2% |
| Total current assets | $264.73M | $244.06M | $247.44M | $221.97M | $204.58M | +8.5% |
| Property, plant & equipment | $167.62M | $170.52M | $173.17M | $175.47M | $177.25M | -1.7% |
| Goodwill & intangibles | $5.31M | $5.47M | $5.63M | $5.78M | $5.94M | -2.9% |
| Total assets | $502.87M | $485.63M | $487.97M | $453.27M | $435.61M | +3.5% |
| Total current liabilities | $52.53M | $47.16M | $49.15M | $45.58M | $41.13M | +11.4% |
| Total debt | $92.65M | $94.54M | $96.37M | $98.01M | $99.76M | -2.0% |
| Total liabilities | $132.82M | $129.40M | $133.33M | $131.42M | $128.80M | +2.7% |
| Retained earnings | -$380.39M | -$382.60M | -$376.30M | -$399.54M | -$404.61M | +0.6% |
| Shareholder equity | $370.04M | $356.23M | $354.64M | $321.86M | $306.81M | +3.9% |
| Working capital | $212.20M | $196.91M | $198.29M | $176.38M | $163.44M | +7.8% |
| Net tangible assets | $364.73M | $350.76M | $349.01M | $316.08M | $300.87M | +4.0% |
| Shares issued | 51.17M | 51.01M | 50.62M | 50.55M | 50.44M | +0.3% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Net income | $2.21M | -$6.30M | $23.24M | $5.07M | -$553.00K | +135.0% |
| Depreciation & amortisation | $3.62M | $3.27M | $3.09M | $2.94M | $2.83M | +10.8% |
| Stock-based compensation | $9.08M | $11.29M | $8.42M | $8.70M | $10.14M | -19.6% |
| Change in working capital | -$278.00K | $6.54M | -$22.25M | $4.09M | -$5.53M | -104.3% |
| Operating cash flow | $16.19M | $16.38M | $15.01M | $22.08M | $8.21M | -1.2% |
| Capital expenditure | -$1.93M | -$1.26M | -$2.19M | -$2.63M | -$8.13M | -53.7% |
| Investing cash flow | -$2.82M | -$4.20M | -$16.39M | -$3.38M | -$9.03M | +32.9% |
| Financing cash flow | $2.69M | -$2.98M | $1.06M | $1.17M | $1.64M | +190.4% |
| Free cash flow | $14.26M | $15.13M | $12.83M | $19.45M | $81.00K | -5.7% |
| End cash position | $125.36M | $109.30M | $100.09M | $100.40M | $80.53M | +14.7% |
Options analytics
Put / call volume
3.86
Put-heavy session
Put / call open interest
3.00
Positioning, not flow
Max pain
30.00
-25.1% from spot
ATM implied vol
0.0%
Nearest strike to spot
Skew (10% OTM)
+173.7%
Puts bid over calls
Call volume
7
Contracts, this expiry
Put volume
27
Contracts, this expiry
Heaviest call OI
20.00
1 contracts
Heaviest put OI
30.00
2 contracts
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Reported vs expected · EPS
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jun 2026 | -0.03 | 0.04 | +250.0% |
| Mar 2026 | -0.16 | -0.12 | +23.4% |
| Dec 2025 | 0.38 | 0.45 | +17.8% |
| Sep 2025 | -0.01 | 0.10 | +850.2% |
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | 0.06 | 5 | $77.95M | +15.5% |
| Next quarter | 0.53 | 5 | $112.40M | +21.0% |
| Current year | 0.52 | 5 | $336.22M | +21.7% |
| Next year | 0.85 | 5 | $392.91M | +16.9% |
Analyst targets & ownership
Mean target$60.57
High target$72.00
Low target$55.00
Implied upside51.24%
Analyst count7
ConsensusNONE
Strong buy / Buy0 / 7
Hold1
Sell / Strong sell0 / 0
Held by insiders1.19%
Held by institutions111.13%
Institutions holding428
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
39.95
+0.25% from price
SMA 20
39.70
+0.88% from price
SMA 50
41.95
-4.54% from price
SMA 100
41.27
-2.97% from price
SMA 200
38.32
+4.52% from price
EMA 12
40.08
-0.09% from price
EMA 26
40.41
-0.89% from price
EMA 50
41.01
-2.34% from price
RSI (14)
47.7
Neutral
MACD (12,26,9)
-0.32
Hist 0.24
ATR (14)
1.25
3.11% of price
Realised vol 30D
28.9%
Annualised
Bollinger upper
41.19
20, 2σ
Bollinger lower
38.22
20, 2σ
50 / 200 cross
Golden
41.95 vs 38.32
Trend bias
Above 200
+4.52%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
0.80
Less volatile than market
Correlation to SPY
0.25
Largely independent
Realised vol 30D
28.9%
Annualised
Market vol 1Y
13.0%
SPY, annualised
Max drawdown 1Y
-31.0%
Peak to trough
Max drawdown 5Y
-66.4%
Peak to trough
ATR 14
1.25
3.11% of price
Beta (reported)
1.03
5Y monthly, from filing
Short interest
Shares short
5.48M
Prior 4.72M
Change vs prior
+16.1%
Shorts adding
% of float
13.79%
Elevated
% of shares out
10.71%
Against total outstanding
Days to cover
11.0
Crowded exit
Float
50.58M
Freely tradeable shares
Exchanges publish short interest twice a month with a settlement lag, so this is roughly two weeks behind. Days to cover divides shares short by average daily volume — it estimates how long covering would take, not whether it will happen.
Rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Jul 31, 26 | TD Cowen | MAINTAINED | Buy | Buy |
| Jul 31, 26 | Truist Securities | MAINTAINED | Buy | Buy |
| Jul 31, 26 | HC Wainwright & Co. | MAINTAINED | Buy | Buy |
| Jul 28, 26 | HC Wainwright & Co. | MAINTAINED | Buy | Buy |
| Jul 16, 26 | Truist Securities | MAINTAINED | Buy | Buy |
| May 8, 26 | HC Wainwright & Co. | MAINTAINED | Buy | Buy |
| Apr 15, 26 | Truist Securities | MAINTAINED | Buy | Buy |
| Feb 27, 26 | HC Wainwright & Co. | MAINTAINED | Buy | Buy |
| Dec 18, 25 | Truist Securities | MAINTAINED | Buy | Buy |
| Nov 10, 25 | Truist Securities | MAINTAINED | Buy | Buy |
| Oct 15, 25 | Truist Securities | MAINTAINED | Buy | Buy |
| Sep 17, 25 | BTIG | DOWNGRADE | Buy | Neutral |
Dividends & splits
Forward rate—
Forward yield0.00%
5-year avg yield—
Payout ratio0.00%
Ex-dividend date—
Next pay date—
Last split1:20
Split dateOct 16, 2013
SEC filings
Periodic Financial Reports
10-Q · 2026-07-30
Corporate Changes & Voting Matters
8-K · 2026-05-18
Periodic Financial Reports
10-Q · 2026-05-07
Corporate Changes & Voting Matters
8-K · 2026-05-01
Proxy Statements
DEFA14A · 2026-03-19
Periodic Financial Reports
10-K · 2026-02-26
Corporate Changes & Voting Matters
8-K · 2026-01-13
Periodic Financial Reports
10-Q · 2025-11-06
Headlines
Vericel (VCEL) Stock Looks Fully Priced After A 31% Gain
Simply Wall St. · 10d ago
Vericel to Present at the 24th Annual Morgan Stanley Global Healthcare Conference on Tuesday, September 15, 2026
GlobeNewswire · 29d ago
MediWound Reports Second Quarter 2026 Financial Results and Provides Corporate Update
GlobeNewswire · 55d ago
Next GLP-1 Billion-Dollar Market: Fireside Chat with Conexeu Sciences CEO Miles Harrison
IPO-Edge.com · 65d ago
Truist Raises Price Target on Vericel to $58 From $54, Keeps Buy Rating
MT Newswires · 68d ago
Vericel Q2 Earnings Call Highlights
MarketBeat · 68d ago
Vericel Corporation (VCEL) Beats Q2 Earnings and Revenue Estimates
Zacks · 69d ago
Vericel Swings to Q2 Net Income, Revenue Rises; Full-Year 2026 Revenue Guidance Raised
MT Newswires · 69d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.